Alinity I STAT HCV
Device
Abbott Laboratories
Total Payments
$32,146
Transactions
13
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $32,146 | 13 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $32,146 | 13 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Alinity I HCV Combo Assay Design Validation Protocol | Abbott Laboratories | $32,146 | 0 |
Top Doctors Receiving Payments for Alinity I STAT HCV
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Boca Raton, FL | $32,146 | 13 |
Ad
Manufacturing Companies
- Abbott Laboratories $32,146
Product Information
- Type Device
- Total Payments $32,146
- Total Doctors 0
- Transactions 13
About Alinity I STAT HCV
Alinity I STAT HCV is a device associated with $32,146 in payments to 0 healthcare providers, recorded across 13 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2020 to 2020. In 2020, $32,146 was paid across 13 transactions to 0 doctors.
The most common payment nature for Alinity I STAT HCV is "Unspecified" ($32,146, 100.0% of total).
Alinity I STAT HCV is associated with 1 research study, including "Alinity I HCV Combo Assay Design Validation Protocol" ($32,146).